Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIA-AF Trial: A Randomized Study of Rhythm-Guided Antithrombotic Strategy After Atrial Fibrillation Ablation in Patients With Prior Drug-Eluting Stent Implantation

NCT07496281 is registered in ClinicalTrials.gov with Ewha Womans University Mokdong Hospital as lead sponsor.

NCT NCT07496281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07496281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIA-AF Trial: A Randomized Study of Rhythm-Guided Antithrombotic Strategy After Atrial Fibrillation Ablation in Patients With Prior Drug-Eluting Stent Implantation
Lead sponsor
Ewha Womans University Mokdong Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
March 1, 2035
Enrollment
2 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), coronary artery disease, drug-eluting stent